Application of machine learning methods to bridge the gap between non-interventional studies and randomized controlled trials in ophthalmic patients with neovascular age-related macular degeneration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of machine learning methods to bridge the gap between non-interventional studies and randomized controlled trials in ophthalmic patients with neovascular age-related macular degeneration
Authors
Keywords
Decision model, Machine learning, Neovascular age-related macular degeneration, Non-interventional study, Predictive analytics, Real world evidence
Journal
Contemporary Clinical Trials
Volume 104, Issue -, Pages 106364
Publisher
Elsevier BV
Online
2021-03-19
DOI
10.1016/j.cct.2021.106364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related choroidal Neovascularisation (IVAN) Trial
- (2020) Rebecca N. Evans et al. OPHTHALMOLOGY
- Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
- (2018) SriniVas R. Sadda et al. OPHTHALMOLOGY
- A review of NICE appraisals of pharmaceuticals 2000-2016 found variation in establishing comparative clinical effectiveness
- (2018) Michael Anderson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Clinically applicable deep learning for diagnosis and referral in retinal disease
- (2018) Jeffrey De Fauw et al. NATURE MEDICINE
- Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen
- (2018) Robyn H. Guymer et al. OPHTHALMOLOGY
- Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials
- (2017) F. Ziemssen et al. BMC Ophthalmology
- Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol
- (2016) Karina Berg et al. OPHTHALMOLOGY
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD
- (2016) Sebastian M. Waldstein et al. OPHTHALMOLOGY
- METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2016) Leah N. Kim et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- 3 Year Clinical Effectiveness of Ranibizumab And Aflibercept For Neovascular AMD: A Retrospective Cohort Study Using Electronic Medical Records From The USA
- (2016) F Milnes et al. VALUE IN HEALTH
- Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration
- (2015) Charles C. Wykoff et al. OPHTHALMOLOGY
- A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD
- (2014) Bora M. Eldem et al. ACTA OPHTHALMOLOGICA
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
- (2014) Allen C. Ho et al. OPHTHALMOLOGY
- A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
- (2013) Ilse Krebs et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
- (2013) Brandon G. Busbee et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
- (2013) Laurent Kodjikian et al. OPHTHALMOLOGY
- Phase 4 research: what happens when the rubber meets the road?
- (2013) M. Crowther Hematology-American Society of Hematology Education Program
- The accomplishments of the global initiative VISION 2020: The Right to Sight and the focus for the next 8 years of the campaign
- (2012) Peter Ackland INDIAN JOURNAL OF OPHTHALMOLOGY
- Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration
- (2012) Michael Larsen et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration
- (2012) Moreno Menghini et al. PLoS One
- Anti-VEGF Treatment Strategies for Wet AMD
- (2012) Jaclyn L. Kovach et al. Journal of Ophthalmology
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial
- (2010) M L Subramanian et al. EYE
- Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration?
- (2010) K Bailey Freund et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- Beyond the Randomized Clinical Trial
- (2008) Brahmajee K. Nallamothu et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started